Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CALS-MZ
- Development stage
- Unknown
- Lead developer
- Wellmed Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
CALS-MZ is a branded generic nutritional supplement marketed by Wellmed Pharma, an Indian pharmaceutical company specializing in PCD (Propaganda Cum Distribution) franchise and third-party manufacturing. The formulation is a combination of essential minerals and vitamins, typically containing calcium (often as calcium citrate or calcium carbonate), magnesium, and zinc, frequently supplemented with vitamin D3 (cholecalciferol). It is designed to support bone health, maintain bone mineral density, and prevent or treat deficiencies that can lead to conditions such as osteoporosis, osteomalacia, and hypocalcemia. As a finished-dose formulation, it is provided in an oral format, usually as a tablet, to facilitate the systemic absorption of these micronutrients necessary for skeletal integrity and metabolic function.
- Brand names
- CALS-MZ
- Other names
- Calcium + Magnesium + Zinc + Vitamin D3 Wellmed Pharma
02
Targets
VDR (Vitamin D receptor)
Beyond the preview
Go deeper on CALS-MZ.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CALS-MZ.